{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:14:50Z","timestamp":1792808090191,"version":"4.5.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,7,1]]},"DOI":"10.1001\/jamaoncol.2020.0465","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:40:31Z","timestamp":1586446831000},"page":"1063","source":"Crossref","is-referenced-by-count":102,"title":["Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection"],"prefix":"10.1001","volume":"6","author":[{"given":"Maria","family":"Gonzalez-Cao","sequence":"first","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mor\u00e1n","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Catalan Institute of Oncology (ICO), Germans Trias i Pujol Hospital, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Dalmau","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garcia-Corbacho","sequence":"additional","affiliation":[{"name":"ICMHO, Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian W. P.","family":"Bracht","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyes","family":"Bernabe","sequence":"additional","affiliation":[{"name":"Hospital Universitario Virgen del Roc\u00edo, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Juan","sequence":"additional","affiliation":[{"name":"Hospital Universitario la Fe de Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de Castro","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remei","family":"Blanco","sequence":"additional","affiliation":[{"name":"Consorci Sanitari de Terrassa, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Drozdowskyj","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Argilaguet","sequence":"additional","affiliation":[{"name":"Infection Biology Laboratory, University Pompeu Fabra, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meyerhans","sequence":"additional","affiliation":[{"name":"Infection Biology Laboratory, University Pompeu Fabra, Barcelona, Spain"},{"name":"Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Blanco","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"},{"name":"University of Vic\u2013Central University of Catalonia (UVic-UCC), Vic, Spain"},{"name":"Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G.","family":"Prado","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"},{"name":"Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Carrillo","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"},{"name":"University of Vic\u2013Central University of Catalonia (UVic-UCC), Vic, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartomeu","family":"Massuti","sequence":"additional","affiliation":[{"name":"Alicante University Hospital, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[{"name":"Puerta de Hierro Hospital, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Molina-Vila","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Mayo de las Casa","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Garzon","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"NanoString Technologies, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martinez-Picado","sequence":"additional","affiliation":[{"name":"IrsiCaixa AIDS Research Institute, University Hospital Germans Trias i Pujol, Badalona, Spain"},{"name":"Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain"},{"name":"Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit, Instituto Oncol\u00f3gico Dr Rosell, Dexeus University Hospital, Barcelona, Spain"},{"name":"Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"cbr200002r1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","article-title":"Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.","volume":"103","author":"Franceschi","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"cbr200002r2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1378\/chest.12-1699","article-title":"Epidemic of lung cancer in patients with HIV infection.","volume":"143","author":"Winstone","year":"2013","journal-title":"Chest"},{"issue":"7724","key":"cbr200002r3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with ant\u2013HIV-1 antibodies maintains viral suppression.","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"issue":"2","key":"cbr200002r4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non\u2013small-cell lung cancer.","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"cbr200002r5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(18)30144-X","article-title":"Durvalumab as third-line or later treatment for advanced non\u2013small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.","volume":"19","author":"Garassino","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"cbr200002r6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma.","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"cbr200002r7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals.","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat Commun"},{"issue":"6","key":"cbr200002r8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12094-018-1981-6","article-title":"Cancer immunotherapy of patients with HIV infection.","volume":"21","author":"Gonzalez-Cao","year":"2019","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"cbr200002r9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jamaoncol.2018.6737","article-title":"Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic review.","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol"},{"issue":"11","key":"cbr200002r10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007401","article-title":"Prediction of PD-L1 inhibition effects for HIV-infected individuals.","volume":"15","author":"Zheltkova","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"33","key":"cbr200002r11","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2017.73.7916","article-title":"Broadening eligibility criteria to make clinical trials more representative: American Society of Clinical Oncology and Friends of Cancer Research joint research statement.","volume":"35","author":"Kim","year":"2017","journal-title":"J Clin Oncol"},{"issue":"33","key":"cbr200002r12","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.2017.73.7338","article-title":"Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology\u2013Friends of Cancer Research HIV Working Group.","volume":"35","author":"Uldrick","year":"2017","journal-title":"J Clin Oncol"},{"issue":"Jun","key":"cbr200002r13","first-page":"2","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer\u2014a phase 1 study.","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"cbr200002r14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122089","article-title":"Enhancement of antiviral CD8+ T-cell responses and complete remission of metastatic melanoma in an HIV-1\u2013infected subject treated with pembrolizumab.","volume":"8","author":"Blanch-Lombarte","year":"2019","journal-title":"J Clin Med"},{"issue":"10","key":"cbr200002r15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2763857\/jamaoncology_gonzalezcao_2020_br_200002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T15:03:13Z","timestamp":1594306993000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2763857"}},"subtitle":["The Phase 2 DURVAST Study"],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.0465","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}